Lactose (India)

Lactose (India) Current Liabilities

The Current Liabilities of Lactose (India) (524202.BO) as of Nov 13, 2026 is 380.77 M INR. In the previous year, Current Liabilities was 422.55 M INR — a change of -9.89% (lower).

Current Liabilities

380.77 MINR

YoY

-9.89%

Last updated:

Current Liabilities of Lactose (India) is 2026 380.77 M INR. Current Liabilities of Lactose (India) was 2025 422.55 M INR. It decreases by -9.89% lower compared to the previous year.

The Lactose (India) Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2019
107.21 M INR
Jan 1, 2020
74.98 M INR
Jan 1, 2021
51.04 M INR
Jan 1, 2022
108.71 M INR
Jan 1, 2023
235.26 M INR
Jan 1, 2024
233.07 M INR
Jan 1, 2025
422.55 M INR
Jan 1, 2026
380.77 M INR
The Lactose (India) Current Liabilities history
YEARCurrent LiabilitiesYoY
380.77 MINR-9.89%
422.55 MINR+81.30%
233.07 MINR-0.93%
235.26 MINR+116.42%
108.71 MINR+112.98%
51.04 MINR-31.93%
74.98 MINR-30.07%
107.21 MINR-0.73%
108.00 MINR-58.68%
261.41 MINR+13.22%
230.88 MINR-57.64%
545.00 MINR+36.06%
400.57 MINR+133.16%
171.80 MINR+10.13%
156.00 MINR+38.67%
112.50 MINR+39.75%
80.50 MINR+21.79%
66.10 MINR+13.18%
58.40 MINR+18.22%
49.40 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Lactose (India) Stock analysis

What does Lactose (India) do? Lactose India Ltd. generates revenue through the manufacturing of pharmaceutical products, primarily lactose monohydrate and disaccharide lactulose. The company produces dry granulated, film and lacquer coated tablets, and offers prebiotic-galacto-oligosaccharides (GOS) for applications in dairy, beverages, bakery, infant nutrition, clinical nutrition, children's products, and geriatric nutrition. Its plant in Vadodara, Gujarat, has an installed capacity of 180 metric tons annually for pharma color coatings. The firm serves segments including liquid dosage forms, solid dosage forms, excipients, and active pharmaceutical ingredients. The company's main products are lactose monohydrate, lactulose, and GOS, which are sold to pharmaceutical manufacturers and food industry players. Lactose monohydrate is used as an excipient in solid dosage forms, while lactulose serves as an active pharmaceutical ingredient. GOS is marketed for use in infant nutrition, clinical nutrition, and other food applications. The plant in Vadodara supports production of these products alongside pharma color coatings. Lactose India Ltd. targets pharmaceutical companies requiring excipients and active ingredients, as well as food and beverage manufacturers seeking prebiotic additives. The firm's product range includes lactose monohydrate for solid dosage forms, lactulose for active pharmaceutical ingredients, and GOS for nutritional applications across multiple consumer segments. Its production capabilities support the growing demand for pharmaceutical and functional food ingredients in India. Lactose (India) is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Lactose (India) stock

Current Liabilities of Lactose (India) is 380.77 M INR in 2026.

Current Liabilities of Lactose (India) changed from 422.55 M INR to 380.77 M INR, representing a -9.89% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Lactose (India) since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Lactose (India) historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Lactose (India)

All Key Metrics — Lactose (India)